BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

27 hedge funds and large institutions have $19.7M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
8
Closed
6
Calls
$8.44M
Puts
$11.2M
Net Calls
-$2.74M
Net Calls Change
-$4.51M

Top Buyers

1
GWM
1
Geneos Wealth Management
Colorado
$8.54M
2
CIC
2
Chase Investment Counsel
Virginia
$2.6M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.88M
4
TFA
4
Toth Financial Advisory
Virginia
$1.8M
5
TCM
5
Traynor Capital Management
Pennsylvania
$294K

Top Sellers

1
HF
1
HRT Financial
New York
$0
2
SBIA
2
Sheaff Brock Investment Advisors
Indiana
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$491K
4
TI
4
Trexquant Investment
Connecticut
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$173K
Name Holding Trade Value Shares
Change 		Shares
Change %
CG
26
Cutler Group
California
$9K +$9K +126 New
SL
27
Savior LLC
Massachusetts
$1K +$1K +10 New
HF
28
HRT Financial
New York
– -$1.79M -38,720 Closed
SBIA
29
Sheaff Brock Investment Advisors
Indiana
– -$694K -15,000 Closed
TI
30
Trexquant Investment
Connecticut
– -$261K -5,647 Closed
Bank of America
31
Bank of America
North Carolina
– -$79K -1,700 Closed
UBS Group
32
UBS Group
Switzerland
– -$32K -696 Closed
CBT
33
Capital Bank & Trust
California
– -$11K -232 Closed
1
2